Clinical Trials on Unresectable Bile Duct Carcinoma in Switzerland
Total 22 results
-
Insel Gruppe AG, University Hospital BernSwiss Cancer LeagueNot yet recruiting
-
Swiss Group for Clinical Cancer ResearchCompletedPain | Liver Cancer | Gallbladder Cancer | Extrahepatic Bile Duct CancerSwitzerland
-
University Hospital, Basel, SwitzerlandUniversity of BaselRecruitingMedical Education | Virtual Reality | Laparoscopy | Bile Duct Injury | GallbladderSwitzerland
-
University Hospital, Basel, SwitzerlandClinical Trial Unit, University Hospital Basel, SwitzerlandCompleted
-
University Hospital Inselspital, BerneCompletedSurgery | Cholecystolithiasis | CholedocholithiasisSwitzerland
-
University Hospital, GenevaCompletedCholecystitis | Cholangitis | Choledocholithiasis | Gallstone Pancreatitis | Gallstone MigrationSwitzerland
-
University Hospital, Basel, SwitzerlandCompleted
-
Fondazione Epatocentro TicinoRecruiting
-
Benedetta Terziroli, MDIntercept Pharmaceuticals; Vifor Pharma; Fondazione Epatocentro TicinoCompletedPrimary Biliary CirrhosisSwitzerland
-
Fondazione Epatocentro TicinoRecruiting
-
TheraOpAstraZenecaActive, not recruitingStage III Non-small Cell Lung Cancer | Locally Advanced | UnresectableSwitzerland
-
Gilead SciencesTerminatedPrimary Sclerosing CholangitisUnited States, Belgium, Israel, Spain, United Kingdom, Australia, Germany, New Zealand, Denmark, France, Japan, Switzerland, Austria, Canada, Finland, Italy
-
CymaBay Therapeutics, Inc.CompletedPrimary Biliary CholangitisUnited States, Spain, France, Korea, Republic of, Denmark, Australia, Italy, United Kingdom, Belgium, Canada, Russian Federation, Romania, Germany, Hungary, Mexico, Turkey, Argentina, Austria, Chile, Czechia, Greece, Israel, New Zealand and more
-
Calliditas Therapeutics Suisse SAActive, not recruitingPrimary Biliary Cholangitis | Liver StiffnessUnited States, Spain, France, Australia, Israel, Canada, Switzerland, Italy, New Zealand, Germany, Poland, Greece, United Kingdom, Belgium, Austria, Czechia, Hungary, Sweden
-
Intercept PharmaceuticalsTerminatedLiver Cirrhosis, BiliaryUnited States, Spain, Korea, Republic of, Australia, Finland, Israel, Lithuania, United Kingdom, Belgium, Netherlands, Estonia, Brazil, Italy, Serbia, Sweden, Argentina, Austria, Canada, Chile, Denmark, France, Germany, Hong Kong, Hun... and more
-
CymaBay Therapeutics, Inc.RecruitingPrimary Biliary CirrhosisUnited States, Korea, Republic of, Belgium, Spain, France, Switzerland, Romania, United Kingdom, Austria, Israel, Australia, Argentina, Canada, Chile, Germany, Greece, Hungary, Italy, Mexico, Netherlands, Poland, Czechia, New Zealand, Turke... and more
-
Hoffmann-La RocheActive, not recruitingUnresectable Hepatocellular CarcinomaCanada, Belgium, Korea, Republic of, Brazil, China, Croatia, Spain, Taiwan, Turkey, Italy, India, United Kingdom, Thailand, Costa Rica, Japan, France, Germany, Austria, Israel, Malaysia, Philippines, Estonia, Russian Federation, Greece, Bulgari... and more
-
IpsenActive, not recruitingPrimary Biliary CirrhosisUnited States, France, Spain, Belgium, Germany, Switzerland, Brazil, United Kingdom, Argentina, Canada, Chile, Italy, South Africa, Turkey
-
GlaxoSmithKlineRecruitingCholestasisUnited States, France, Japan, United Kingdom, Bulgaria, Germany, Greece, Italy, China, Argentina, Belgium, Brazil, Canada, Czechia, Israel, Mexico, Poland, Russian Federation, Spain, Switzerland
-
Incyte CorporationRecruitingMetastatic Cholangiocarcinoma | Unresectable CholangiocarcinomaUnited States, Canada, Belgium, France, Germany, Italy, China, Spain, Japan, United Kingdom, Netherlands, Switzerland, Austria, Denmark, Finland, Ireland, Israel, Norway, Sweden
-
GlaxoSmithKlineActive, not recruitingPruritusUnited States, France, Spain, Israel, Belgium, Canada, Czechia, Italy, United Kingdom, China, Germany, Mexico, Japan, Brazil, Poland, Russian Federation, Greece, Argentina, Switzerland, Bulgaria
-
MedImmune LLCCompletedNSCLC | Resectable | Early-stageUnited States, Canada, Switzerland, Italy, France, Portugal, Spain